ArticleCommunications medicine2024

Poor compliance with germline testing recommendations in colorectal cancer patients undergoing molecular residual disease testing.

Suzanne Schrock-Kelley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.